Volta Medical Appoints Bill Hoffman as Executive Chairman
Volta Medical has appointed Bill Hoffman as the Executive Chairman of its Board of Directors, announced in a press release. Hoffman, who previously served as CEO of Inari Medical, is recognized for leading the company to significant growth and its eventual acquisition by Stryker for $4.9 billion.
Volta Medical, a health technology company based in Marseille, France, focuses on developing AI solutions to assist electrophysiologists in cardiac ablation procedures. Hoffman's appointment comes as the company aims to expand global access to its AI-driven solutions, which have shown improved efficacy outcomes for atrial fibrillation patients.
In addition to Hoffman's appointment, Jerome Kalifa, MD, PhD, has been named Executive Vice Chairman while continuing his role as Chief Medical Officer. This leadership change follows the publication of the TAILORED-AF clinical trial in Nature Medicine, highlighting the effectiveness of Volta's AI-guided procedures.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 22 Aqurio Named Finalist for 2026 AI Startup of the Year Sep 22 Tsingke Introduces Validation Workflow for AI Designed Proteins Sep 22 QC Healthcare Partners With Sanguina for AI Blood Health Screening Sep 22 RIVANNA Files 100th Patent for Ultrasound AI Sep 22 Ultima Genomics Platform Selected for Precure's One Million Sample DatasetLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Atman Health Wins ARPA-H Award to Build Heart Failure AI
Vantora Secures More Than $100 Million From Silversmith
ARPA-H Awards UpDoc Up to $9.2 Million for Clinical AI
Drivvr AI Names Brian Voss National Sales Director
Konko AI Raises $6 Million for Patient Journey Platform
Daily AI Brief: the AI news that matters, in your inbox.